glp-1 type 1 diabetes news diaTribe.com Releases A Consensus on and Diabetics. : r/ Type1Diabetes GLP-1-based therapies for diabetes, obesity
Description
The global obesity treatment market is expanding at unprecedented speed, with sales of weight-loss medications forecast to rise dramatically over the next decade.
Alabamas attorney general recently filed a lawsuit against a medical spa alleging that it administered unapproved versions of GLP-1 weight loss drugs to patients without informing them that the formulations were not authorized by the FDA
Genetic testing that reveals peptide pathway predispositions can provide context for selecting between compounded or branded options tailored to individual biology
Importantly, increasing the endogenous production of GLP-1 by different mechanisms or by increasing the number of intestinal L-cells that tend to produce this hormone may be another effective therapeutic approach to managing T2DM
The company is also under investigation by the FDA regarding its practices around compounded GLP-1 medications for weight management
Stuck on semaglutide or tirzepatide
